GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MaxCyte Inc (STU:MYE0) » Definitions » FCF Margin %

MaxCyte (STU:MYE0) FCF Margin % : -49.17% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MaxCyte FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. MaxCyte's Free Cash Flow for the three months ended in Jun. 2024 was €-4.76 Mil. MaxCyte's Revenue for the three months ended in Jun. 2024 was €9.69 Mil. Therefore, MaxCyte's FCF Margin % for the quarter that ended in Jun. 2024 was -49.17%.

As of today, MaxCyte's current FCF Yield % is -6.98%.

The historical rank and industry rank for MaxCyte's FCF Margin % or its related term are showing as below:

STU:MYE0' s FCF Margin % Range Over the Past 10 Years
Min: -75.15   Med: -44.71   Max: -2.96
Current: -56.1


During the past 12 years, the highest FCF Margin % of MaxCyte was -2.96%. The lowest was -75.15%. And the median was -44.71%.

STU:MYE0's FCF Margin % is ranked worse than
72.58% of 828 companies
in the Medical Devices & Instruments industry
Industry Median: -5.67 vs STU:MYE0: -56.10


MaxCyte FCF Margin % Historical Data

The historical data trend for MaxCyte's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MaxCyte FCF Margin % Chart

MaxCyte Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -46.60 -41.48 -42.82 -75.14 -61.49

MaxCyte Quarterly Data
Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -117.35 -111.92 0.42 -100.23 -49.17

Competitive Comparison of MaxCyte's FCF Margin %

For the Medical Devices subindustry, MaxCyte's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MaxCyte's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MaxCyte's FCF Margin % distribution charts can be found below:

* The bar in red indicates where MaxCyte's FCF Margin % falls into.



MaxCyte FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

MaxCyte's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-23.279/37.861
=-61.49 %

MaxCyte's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-4.764/9.689
=-49.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MaxCyte FCF Margin % Related Terms

Thank you for viewing the detailed overview of MaxCyte's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


MaxCyte Business Description

Traded in Other Exchanges
Address
9713 Key West Avenue, Suite 400, Rockville, MD, USA, 20850
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

MaxCyte Headlines

No Headlines